Peritoneal carcinomatosis [PDF]
World Journal of Gastroenterology, 2013 Several gastrointestinal and gynecological malignancies have the potential to disseminate and grow in the peritoneal cavity. The occurrence of peritoneal carcinomatosis (PC) has been shown to significantly decrease overall survival in patients with liver
Ansaloni L +10 more
core +9 more sources
Сибирский онкологический журнал, 2016 The literature review examines the main pathological and morphogenetic aspects of the development of peritoneal carcinomatosis and its molecular and biological features.
I. V. Stepanov +2 more
doaj +5 more sources
Intraperitoneal administration of mRNA encoding interleukin-12 for immunotherapy in peritoneal carcinomatosis [PDF]
Journal of NanobiotechnologyPeritoneal carcinomatosis is an advanced stage of cancer with very limited treatment options. Locoregional immunotherapy is being evaluated as a way to improve efficacy and limit toxicity.
Leire Arrizabalaga +14 more
doaj +2 more sources
Abdominal Sarcoidosis Mimicking Peritoneal Carcinomatosis [PDF]
Annals of Coloproctology, 2018 We present a patient diagnosed with skin sarcoidosis, breast cancer, pulmonary tuberculosis, and peritoneal sarcoidosis with a past history of colorectal cancer.
Won Seok Roh +3 more
doaj +5 more sources
Peritoneal carcinomatosis from colorectal cancer [PDF]
British Journal of Surgery, 2002 Abstract Background Aggressive therapeutic regimens have been advocated for the treatment of peritoneal carcinomatosis from colorectal cancer. It is essential to understand the clinical and histological features that govern the natural history of this condition if the efficacies of novel therapeutic ...
David Jayne +3 more
openalex +3 more sources
Can inter-observer consistency be achieved in the laparoscopic assessment of the peritoneal carcinomatosis index score in peritoneal metastasis? A pilot study [PDF]
Pleura and PeritoneumThe main prognostic factor for peritoneal metastasis (PM) is the complete resection of the disease during cytoreductive surgery. Accurate patient selection is therefore essential for determining eligibility for this type of surgery.
Astruc Audrey +8 more
doaj +2 more sources
Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC
World Journal of Surgical Oncology, 2023 Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the survival of selected patients with peritoneal metastasis. A major cause of treatment-related morbidity after CRS/HIPEC is infection and sepsis. HIPEC
Lilian Roth +6 more
doaj +1 more source
New views on pathogenesis and diagnosis of peritoneal carcinomatosis
Креативная хирургия и онкология, 2023 Peritoneal metastasis occurs in a number of heterogeneous tumors originating from the ovaries, stomach, intestines, pancreas, lungs, breast, and melanoma. Peritoneal carcinomatosis significantly reduces overall survival.
K. R. Ishmuratova, K. Sh. Gantsev
doaj +1 more source
The levels of plasma MiR-9 and MiR-106a are associated with the development of peritoneal carcinomatosis in patients with gastric cancer. [PDF]
BMC CancerChen Q +8 more
europepmc +3 more sources
Long-term results and prognostic factors of gastric cancer patients with microscopic peritoneal carcinomatosis. [PDF]
PLoS ONE, 2012 BACKGROUND: Clinical significance of microscopic peritoneal carcinomatosis remained unclear. The aim of this study was to evaluate the prognostic value of microscopic peritoneal carcinomatosis in gastric cancer.
Xiaowen Liu +3 more
doaj +1 more source